OTCMKTS:HCYTD

H-CYTE - HCYTD News Today

$2.02

-1.98 (-49.50%)

(As of 07/11/2022)

Add

Compare

Today's Range: $2.02
▼
$2.77
50-Day Range: $0.02
▼
$4.00
52-Week Range: $2.02
▼
$77.00

Volume: 400 shs
Average Volume: 103 shs
Market Capitalization: $521,160.00

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Get H-CYTE News Delivered to You Automatically

HCYTD Media Mentions By Week

HCYTD Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

HCYTD
News Sentiment
▼
0.00

0.38
▲
Average
Medical
News Sentiment

HCYTD News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

HCYTD Articles
This Week
▼
1

0
▲
HCYTD Articles
Average Week

Source

Source	Headline
	H-CYTE Completes Acquisition of Jantibody finance.yahoo.com - September 8 at 8:15 AM
	H-CYTE to Expect the Completed Acquisition of Jantibody Within 30 Days apnews.com - July 23 at 2:03 PM
	H-CYTE Announces 1-for-1,000 Reverse Stock Split finance.yahoo.com - June 13 at 9:25 AM
	H-CYTE Announces Proceeds of $1.05 Million from Warrant Exercise finance.yahoo.com - March 4 at 7:46 PM
	H-CYTE Inc (HCYT) nasdaq.com - February 7 at 10:18 PM
	H-CYTE signs letter of intent to acquire Catheter Precision seekingalpha.com - January 11 at 9:47 AM
	H-CYTE Enters Into Letter of Intent for Acquisition of Catheter Precision, Inc. finance.yahoo.com - January 11 at 9:47 AM
	H-CYTE Names Michael Yurkowsky Chief Executive Officer finance.yahoo.com - December 6 at 10:05 AM
	Italian court seeks opinion on Berlusconi's health due to trial delays au.finance.yahoo.com - September 9 at 9:48 PM
	H-CYTE Combines Clinical Outcomes and Scientific Development to Launch New Centers for Respiratory Health finance.yahoo.com - September 8 at 4:58 PM
	Jefferson Lines takes proactive steps toward crisis management with TSA I-STEP training ca.finance.yahoo.com - July 7 at 7:31 PM
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
	Scanfil plc: Managers' transactions – Jokitalo in.finance.yahoo.com - July 7 at 7:31 PM
	H-CYTE Announces Publication of Additional Data that Further Supports Efficacy of Innovative PRP-PBMC Treatment Aimed at Helping to Improve Overall Lung Health finance.yahoo.com - July 6 at 8:50 AM
	Constellium supplies advanced aluminium solutions for the electric Audi e-tron GT in.finance.yahoo.com - July 1 at 7:54 AM
	NetNumber Named as One of the “10 Most Disruptive Companies of 2021” by Exceleon Magazine au.finance.yahoo.com - July 1 at 7:54 AM
	H-CYTE Announces Publication of Positive Real-World Data Relating to the Use of Innovative Treatment (PRP-PBMC) Aimed at Helping Improve Overall Lung Health finance.yahoo.com - June 29 at 10:09 AM
	New Providence CEO: 'We have a responsibility and accountability to the community' msn.com - October 4 at 2:13 PM
	Robert Greif named Chief Executive Officer of H-CYTE feeds.benzinga.com - September 29 at 6:39 PM
	Three Canada Stocks who's Volume Surged on Bullish Signals: $VS $PPR $QRO marketwatch.com - September 27 at 11:46 AM
	H-CYTE Extends Rights Offering to 5:00 PM Eastern Time on Friday, September 11, 2020 finance.yahoo.com - September 2 at 9:36 AM
	TSX rises on energy gains, U.S. services sector rebound www.nasdaq.com - July 6 at 1:52 PM
	CANADA STOCKS-TSX rises on energy gains, U.S. services sector rebound www.reuters.com - July 6 at 1:52 PM
	Prairie Provident Provides an Update on Lending Facility finance.yahoo.com - April 21 at 6:31 PM
	Prairie Provident Resources Announces Fourth Quarter and Year-End 2019 Financial and Operating Results www.globenewswire.com - March 26 at 11:14 PM
	Prairie Provident Resources Announces Updated Corporate Presentation www.globenewswire.com - February 18 at 8:12 AM
	H-CYTE Bolsters Board of Directors With Appointment of Dr. Atta Behfar to its Board of Directors finance.yahoo.com - January 28 at 8:39 AM
	H-CYTE Raises $6 Million to Accelerate FDA Approval Process of Next Generation Cellular Therapy for COPD finance.yahoo.com - January 28 at 8:39 AM
	H-CYTE Issues Letter to Shareholders finance.yahoo.com - January 28 at 8:39 AM

Get H-CYTE News Delivered to You Automatically

This page (OTCMKTS:HCYTD) was last updated on 9/8/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial Subscription Here

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms